Drug Interactions

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/97

flashcard set

Earn XP

Description and Tags

Chapter 3: 2025 Naplex Book

Last updated 2:19 AM on 6/17/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

98 Terms

1
New cards
What is a pharmacodynamic drug interaction?
A pharmacodynamic interaction is an effect or change that a drug has on the body.
2
New cards
When do pharmacodynamic interactions occur?
They occur when two or more drugs are given together and their effects impact each other.
3
New cards
What types of pharmacodynamic interactions can occur?
Additive, antagonistic, and synergistic.
4
New cards
What is a pharmacokinetic drug interaction?

A pharmacokinetic interaction occurs when one drug affects the absorption, distribution, metabolism, or excretion (ADME) of another drug. (effect that the BODY has on a drug)

5
New cards
What causes additive pharmacodynamic effects at the same receptor?
Multiple drugs acting as agonists at the same receptor can produce additive effects.
6
New cards
What is an example of additive effects from drugs acting at the same receptor?
Opioids are mu-receptor agonists. Taking two opioids together can cause additive effects.
7
New cards
What adverse effects can occur when two opioids are taken together?
Increased sedation, respiratory depression, and risk of death.
8
New cards
Can drugs acting at different receptors still produce additive effects?
Yes. Drugs with different MOAs or receptors can still produce additive effects if they have similar end effects.
9
New cards
How do benzodiazepines and opioids produce additive effects despite different receptors?
Benzodiazepines enhance GABA activity while opioids act at mu receptors, but both cause sedation and respiratory depression.
10
New cards
What safety concerns exist with concurrent benzodiazepine and opioid use?
The combination can cause fatal overdose, carries a boxed warning (BBW), and requires close patient monitoring.
11
New cards
Where does absorption of most oral drugs occur?
The small intestine.
12
New cards
What are distribution, metabolism, and excretion?
Distribution = movement through blood and tissues; Metabolism = enzymatic reactions; Excretion = removal of the drug or metabolites from the body.
13
New cards
Which medications should generally be separated from polyvalent cations or other binding agents?
Quinolones, tetracyclines, levothyroxine, and oral bisphosphonates.
14
New cards
How can increased gastrointestinal pH affect drug absorption?
Some drugs require an acidic gut for absorption; increasing GI pH can decrease their absorption.
15
New cards
Which acid-suppressing drugs commonly increase gastrointestinal pH?
H2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs).
16
New cards
What is an example of a drug interaction caused by increased gastrointestinal pH?
H2RAs and PPIs can decrease the absorption of itraconazole.
17
New cards
What can happen when itraconazole absorption is decreased by acid-suppressing drugs?
It can result in untreated or resistant infections.
18
New cards
Where do most pharmacokinetic drug interactions involving metabolism occur?
During metabolism (Phase I or Phase II reactions) in the liver.
19
New cards
Can metabolism-based drug interactions be beneficial or harmful?
Yes, they can be either beneficial or harmful.
20
New cards
How is ritonavir used to beneficially affect darunavir therapy?
Ritonavir inhibits the metabolism of darunavir, boosting darunavir levels and increasing its efficacy in treating HIV.
21
New cards
How does clarithromycin affect warfarin therapy?
Clarithromycin inhibits warfarin metabolism, increasing INR and bleeding risk.
22
New cards
How does rifampin affect warfarin therapy?
Rifampin induces warfarin metabolism, decreasing INR and increasing clotting risk.
23
New cards
How may warfarin dosing need to be adjusted when interacting drugs are used?
The warfarin dose may need to be decreased with clarithromycin or increased with rifampin to maintain the desired INR.
24
New cards
What is the primary route of drug excretion?
Renal excretion.
25
New cards
How can drug interactions affect renal excretion?
Drug interactions can either decrease or increase renal excretion.
26
New cards
How does probenecid affect penicillin excretion?
Probenecid blocks the renal excretion of penicillin.
27
New cards
Why might probenecid be given with penicillin?
It increases penicillin levels, which can help the drug cross the blood-brain barrier (BBB) and treat neurosyphilis.
28
New cards
What are signs of salicylate (aspirin) toxicity?
Tinnitus and metabolic acidosis.
29
New cards
What is the primary function of CYP450 enzymes?
CYP450 enzymes catalyze Phase I reactions.
30
New cards
How do CYP450 enzymes help facilitate renal excretion?
They can uncover or add a polar (water-loving) group to a compound.
31
New cards
What important endogenous compounds can be produced through CYP450 Phase I reactions?
Examples include cholesterol and cortisol.
32
New cards
Where are CYP450 enzymes primarily expressed?
In the liver.
33
New cards
Approximately how many CYP enzymes have been identified, and how many metabolize most drugs?
More than 50 CYP enzymes have been identified, and 6 of them metabolize most drugs.
34
New cards
Which CYP enzyme metabolizes the largest proportion of drug substrates?
CYP3A4 metabolizes approximately 34% of all CYP450 drug substrates.
35
New cards
What factors can affect CYP450 enzyme function?
Genetics and drugs that act as enzyme inhibitors or inducers.
36
New cards
Why are prodrugs used by manufacturers?
To increase bioavailability or help prevent drug abuse.
37
New cards
What is the active metabolite of codeine?
Morphine.
38
New cards
Which phase of metabolism primarily involves CYP450 enzymes?
Phase I metabolism.
39
New cards
Can non-CYP450 enzymes affect drug metabolism?
Yes. Other enzymes, including Phase II enzymes, can alter drug levels.
40
New cards
What is UGT1A1?
UGT1A1 (uridine diphosphate glucuronosyltransferase 1A1) is a Phase II enzyme involved in drug metabolism.
41
New cards
Why is bictegravir commonly used as an example of non-CYP450 metabolism?
Bictegravir is a substrate of both CYP3A4 and UGT1A1.
42
New cards
How can CYP3A4 or UGT1A1 inhibitors and inducers affect bictegravir?
They can alter the metabolism of bictegravir.
43
New cards
What is N-acetyltransferase (NAT)?
NAT is a Phase II enzyme involved in acetylation reactions.
44
New cards
Why is NAT important in pharmacogenomics?
NAT is highly polymorphic, meaning genetic differences can affect enzyme activity.
45
New cards
Why can patients experience different levels of isoniazid toxicity?
Differences in NAT activity can cause different rates of acetylation, leading to differences in isoniazid toxicity.
46
New cards
How do CYP enzyme inhibitors affect substrate drug concentrations?
CYP inhibitors decrease enzyme function and metabolism, causing substrate drug concentrations to increase.
47
New cards
How do CYP enzyme inhibitors affect prodrugs?
CYP inhibitors reduce conversion of prodrugs to their active forms, decreasing active drug concentrations.
48
New cards
How quickly does CYP enzyme inhibition occur?
Enzyme inhibition is fast; effects are typically seen within a few days and end soon after the inhibitor is discontinued.
49
New cards
How are CYP inhibitors classified and why are some drugs involved in many interactions?
FDA labels CYP inhibitors as strong, moderate, or weak. Many interactions involve moderate or strong CYP3A4 inhibitors, while some drugs (e.g., amiodarone) inhibit multiple CYP enzymes.
50
New cards
How do CYP enzyme inducers affect substrate drug concentrations?
CYP inducers increase enzyme production or activity, increasing metabolism and decreasing substrate drug concentrations.
51
New cards
What clinical problem can CYP enzyme inducers cause?
Therapeutic failure.
52
New cards
How do CYP enzyme inducers affect prodrugs?
CYP inducers increase conversion of prodrugs to their active forms, increasing active drug concentrations.
53
New cards
How are CYP enzyme inducers classified?
FDA labels CYP inducers as strong, moderate, or weak.
54
New cards
Why are some CYP inducers involved in many drug interactions?
Many are moderate or strong CYP3A4 inducers and/or induce multiple CYP enzymes (e.g., rifampin).
55
New cards
What does the G ♥ PACMAN mnemonic stand for?
Grapefruit; Protease inhibitors (especially ritonavir); Azole antifungals (fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, isavuconazonium); Cyclosporine and cobicistat; Macrolides (clarithromycin and erythromycin, not azithromycin); Amiodarone (and dronedarone); Non-DHP calcium channel blockers (diltiazem and verapamil).
56
New cards

what menmonic is used to remember the common CYP450 inhibitors?

G PACMAN

57
New cards
How should CYP inhibitor interactions be managed?
Perform therapeutic drug monitoring; monitor for therapeutic effects, ADRs, and toxicity; consider decreasing the substrate dose (unless it is a prodrug) or using an alternative drug.
58
New cards
What does the PS PORCS mnemonic stand for?
Phenytoin, Smoking, Phenobarbital, Oxcarbazepine, Rifampin (including rifabutin and rifapentine), Carbamazepine, and St. John's wort.
59
New cards
Which CYP inducer is also an auto-inducer?
Carbamazepine.
60
New cards
Why do CYP inducer interactions have a lag time?
Induction requires production of additional enzymes, so full effects may take up to 4 weeks to appear and 2–4 weeks to disappear after the inducer is stopped.
61
New cards
What is the function of P-glycoprotein (P-gp) efflux pumps?
P-gp efflux pumps protect against foreign substances by transporting them out of cells.
62
New cards
What does "efflux" mean, and how do P-gp pumps affect drugs in the GI tract?
Efflux means "to flow out." P-gp pumps drugs and metabolites into the gut, where they can be excreted in the stool.
63
New cards
How does inhibition of P-gp affect a P-gp substrate?
P-gp inhibition decreases drug efflux into the gut, increasing absorption and substrate drug levels.
64
New cards
How can efflux pumps contribute to chemotherapy resistance?
Some efflux pumps remove chemotherapeutic agents from cancer cells, reducing drug effectiveness.
65
New cards
What is the function of the OATP1B1/3 transporter?
OATP1B1/3 transports drugs and other compounds from the blood into the liver.
66
New cards
What are the common P-gp substrate anticoagulants and cardiovascular drugs?

Anticoagulants: apixaban and rivaroxaban.

Cardiovascular drugs: digoxin, diltiazem, verapamil.

67
New cards
What are the common P-gp substrate HCV drugs, immunosuppressants, and other substrates?

HCV: sofosbuvir.

Immunosuppressants: cyclosporine, tacrolimus.

Others: colchicine

68
New cards
What are the common P-gp inducers?
Carbamazepine, dexamethasone, phenobarbital, phenytoin, rifampin, St. John's wort, and tipranavir.
69
New cards
What anti-infectives are common P-gp inhibitors?
Clarithromycin, itraconazole, and posaconazole.
70
New cards

What cardiovascular drugs are common P-gp inhibitors?

Amiodarone and verapamil.

71
New cards
What HCV drugs, HIV drugs, and other agents are common P-gp inhibitors?
HCV: ledipasvir. HIV: cobicistat and ritonavir. Others: cyclosporine, flibanserin, and ticagrelor.
72
New cards
What is enterohepatic recycling?
After a drug is metabolized in the liver, it can be transported through the bile to the gut, reabsorbed (primarily in the small intestine), return to the liver through the portal vein, and be reused.
73
New cards
What is the effect of enterohepatic recycling on drug therapy?
Enterohepatic recycling increases the duration of action of many drugs.
74
New cards
Which drugs commonly undergo enterohepatic recycling?
Some antibiotics, some NSAIDs, mycophenolate, and ezetimibe.
75
New cards
Why does amiodarone increase the effects of warfarin?
Amiodarone inhibits CYP2C9, decreasing metabolism of the more potent warfarin isomer and increasing INR and bleeding risk.
76
New cards
How should warfarin be managed when used with amiodarone?
If starting warfarin in a patient already taking amiodarone, start at ≤5 mg. If adding amiodarone to warfarin, decrease the warfarin dose by 30–50% and monitor INR.
77
New cards
Why does amiodarone increase digoxin toxicity risk?
Amiodarone inhibits P-gp, and digoxin is a P-gp substrate, causing decreased digoxin excretion and increased digoxin levels and toxicity.
78
New cards
What cardiovascular risks occur when amiodarone and digoxin are used together?
Both lower heart rate, increasing the risk of bradycardia, arrhythmias, and death.
79
New cards
How should digoxin be managed when used with amiodarone?
If starting digoxin in a patient on amiodarone, use a low dose (e.g., 0.125 mg daily). If adding amiodarone to digoxin, decrease the oral digoxin dose by 50%.
80
New cards
What monitoring is required when patients take both amiodarone and digoxin?
Monitor for digoxin toxicity (nausea, vomiting, vision changes) and monitor heart rate.
81
New cards
How do loop diuretics affect electrolyte levels?
Loop diuretics decrease potassium, magnesium, calcium, and sodium.
82
New cards
How do electrolyte abnormalities affect digoxin toxicity risk?
Low potassium, magnesium, or calcium worsen arrhythmias. Low potassium and magnesium and high calcium increase digoxin toxicity risk.
83
New cards
How should digoxin and loop diuretics be managed together?
Monitor electrolytes and correct abnormalities. Digoxin is cleared by P-gp and excreted by the kidneys, so renal impairment increases digoxin levels and toxicity risk; decrease the digoxin dose or frequency, or discontinue if needed.
84
New cards
Which drugs commonly cause additive decreases in heart rate when used together?
Amiodarone, digoxin, beta-blockers, clonidine, diltiazem, verapamil, and dexmedetomidine (Precedex). Diltiazem/verapamil and beta-blockers are often used for rate control; clonidine and beta-blockers are also used to lower blood pressure.
85
New cards
How should patients taking multiple heart rate-lowering drugs be monitored?
Monitor heart rate; normal is generally 60–100 BPM (may be lower depending on patient history and physical state).
86
New cards
Which statins are CYP3A4 substrates commonly involved in interactions?
Lovastatin, simvastatin, and atorvastatin.
87
New cards
Which drugs are considered strong CYP3A4 inhibitors that interact with statins?
Protease inhibitors (including ritonavir), cobicistat, clarithromycin, erythromycin, azole antifungals, cyclosporine, and grapefruit/grapefruit juice.
88
New cards
What is the risk of combining CYP3A4 substrate statins with strong CYP3A4 inhibitors?
Increased statin levels increase the risk of myopathy; severe cases with high CPK can cause rhabdomyolysis and acute renal failure (ARF).
89
New cards
Which statins are contraindicated with strong CYP3A4 inhibitors, and what alternatives are recommended?
Simvastatin and lovastatin are contraindicated. Consider pitavastatin, pravastatin, or rosuvastatin instead.
90
New cards
How do CYP2C9 inhibitors and inducers affect warfarin?
CYP2C9 inhibitors increase warfarin levels, INR, and bleeding risk; CYP2C9 inducers decrease warfarin levels and INR and increase clotting risk.
91
New cards
Which drugs commonly interact with warfarin through CYP2C9, and how should patients be monitored?
Inhibitors: azole antifungals, sulfamethoxazole/trimethoprim, amiodarone, metronidazole. Inducers: rifampin and St. John's wort. Monitor INR (usually goal 2–3; 2.5–3.5 for some high-risk indications such as a mechanical mitral valve). Some drugs, such as amiodarone, may require prophylactic warfarin dose adjustment.
92
New cards

Why should codeine be avoided in CYP2D6 ultra-rapid metabolizers?

They convert codeine to morphine rapidly, increasing the risk of morphine toxicity; avoid codeine.

93
New cards

Why is codeine ineffective in CYP2D6 poor metabolizers and what should be done?

They convert less codeine to morphine, resulting in poor analgesia; use an alternative analgesic.

94
New cards

Why can clopidogrel become less effective? which enzyme activates it?

CYP2C19; inhibitors of CYP2C19 (omeprazole etc) and poor metabolizers reduce the conversion to the active form which decreases antiplatelet activity

95
New cards

What is chelation and give a common example?

Chelation occurs when a drug binds polyvalent cations, forming an insoluble complex that reduces absorption. Example: quinolones bind calcium-containing products and are not absorbed

96
New cards

How does sodium bicarbonate increase salicylate excretion?

Sodium bicarbonate alkalinizes the urine, causing salicylate to become ionized. Ionized drugs are more water-soluble, remain in the urine, and are less likely to be reabsorbed, increasing excretion.

97
New cards

Why is valacyclovir preferred over acyclovir?

Valacyclovir is a prodrug converted to acyclovir and has higher bioavailability, allowing less frequent dosing.

98
New cards

How are CYP inducer interactions monitored and managed?

Monitor therapeutic drug levels and clinical response. Consider increasing the substrate dose (unless it is a prodrug) or using an alternative drug.